Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1995 | 09-1995 | 06-1995 | 03-1995 | 12-1994 | |
| Sales | 5,743 | 6,186 | 7,623 | 7,833 | 7,688 |
| Cost of Goods | 0 | 0 | 0 | 0 | -21,099 |
| Gross Profit | 5,743 | 6,186 | 7,623 | 7,833 | 29,892 |
| Operating Expenses | 13,308 | 12,201 | 11,625 | 11,631 | 33,875 |
| Operating Income | -7,565 | -6,015 | -4,002 | -3,798 | -5,187 |
| Interest Expense | 235 | 219 | 379 | 372 | 518 |
| Other Income | -11 | -911 | 0 | 0 | 1 |
| Pre-tax Income | -7,811 | -7,145 | -4,381 | -4,170 | -5,705 |
| Net Income Continuous | -7,810 | -7,146 | -4,381 | -4,170 | -5,705 |
| Net Income | $-7,810 | $-7,146 | $-4,381 | $-4,170 | $-5,705 |
| EPS Basic Total Ops | -0.38 | -0.37 | -0.22 | -0.22 | -0.30 |
| EPS Basic Continuous Ops | -0.38 | -0.37 | -0.22 | -0.22 | -0.30 |
| EPS Diluted Total Ops | -0.38 | -0.37 | -0.22 | -0.22 | -0.30 |
| EPS Diluted Continuous Ops | -0.38 | -0.37 | -0.22 | -0.22 | -0.30 |
| EBITDA(a) | $-7,565 | $-6,015 | $-4,002 | $-3,798 | $-5,187 |